Medical Advocates
Fosamprenavir (Lexiva/GW433908)
 


 		 Main Page

New and Noteworthy
Journal Data
 Conference Data
 FDA Updates
 Guidelines
 Pediatric Data
 Perinatal Data
 Protease Inhibitors: General Data
 Manufacture's Information
 Lexiva December 2007 Revised Label
 		  
ARV Drugs Main Page Main New/Newsworthy Home Page      
This web page is best viewed by using INTERNET EXPLORER
Last Update:  June 26, 2010
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
New and Noteworthy
     
June 2010
 
FDA Updates
     
Cardiovascular Problems with Lexiva (fosamprenavir)
Pediatric Indications
 

USPHS Pediatric Antiretroviral Drug Information
 US Treatment Guidelines

Journal Papers, Abstracts, andCommentaries
 
Conference Reports, Abstracts and Posters
Perinatal Data
       
Guidelines
 
     United States

          Internet Documents

  FULL TEXT PDF DOCUMENT
Public Health Service Task Force Recommendations for Use of Antiretroviral Drugs
in Pregnant HIV-Infected Women for Maternal Health and Interventions to Reduce
Perinatal HIV  Transmission in the United States.
Perinatal HIV Guidelines Working Group.
November 2, 2007
Guidelines
 
  FULL TEXT PDF DOCUMENT
Safety and Toxicity of Individual Antiretroviral Agents in Pregnancy
 Perinatal HIV Guidelines Working Group.
November 2, 2007
Guidelines

 
ARV Drugs Main Page Main New/Newsworthy Home Page      

Fosamprenavir